-+ 0.00%
-+ 0.00%
-+ 0.00%

ATOSSA THERAPEUTICS ANNOUNCES POSITIVE FDA FEEDBACK, ADVANCES TOWARD IND FOR (Z)-ENDOXIFEN CLINICAL PROGRAM IN ER+/HER2- METASTATIC BREAST CANCER

Reuters·07/29/2025 11:45:09

Please log in to view news